Glucose control in non-ICU; no right answer

This large meta-analysis evaluated the risks and benefits of intensive or liberal glucose control in non-ICU patients and found no difference for most outcomes (stroke, MI, death), a reduction in rates of infections (relative risk 0.44, CI 0.21 to 0.77), but an increase in rates of hypoglycemia (relative risk 1.58, CI 0.97 to 2.57). Intensive glucose control does not appear to substantially benefit non-ICU patients overall (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment